FACTS 001, which released data at CROI, found no evidence of protection overall associated with the vaginal gel. Partners Demonstration Project, which reported data at the same meeting, found that serodiscordant couples using oral PrEP and/or ART had very low levels of HIV transmission. In this webinar, we discussed what these and other data meant for women, including young and adolescent girls.
After FACTS: What’s next for HIV prevention in women?
Success with PrEP: Next Steps to Support Policy Decisions in Southern and East Africa
Convened on 26 October 2014 by AVAC, UNAIDS and WHO, this meeting brought together representatives of ministries of health and national AIDS councils, PrEP researchers and participants from research and demonstration sites where PrEP is currently being delivered in Kenya, Mozambique, South Africa, Uganda and Zimbabwe, along with funders, manufacturers and HIV advocates and activists. Through a series of presentations, moderated discussions and small group work, participants shared current experiences and helped define a structured approach to considering the integration of PrEP in HIV prevention programs in the region. In addition, some of the knowledge gaps that remain to be researched were identified.
AVAC Report 2014/15: HIV Prevention on the Line
In AVAC Report 2014/15: HIV Prevention on the Line, we take on the current state of global targets for the AIDS response, looking beyond pithy slogans to explore what’s in place and what’s not in terms of targets, resources and action to begin to end the AIDS epidemic. We also provide concise updates and calls to action on key prevention interventions including AIDS vaccines, voluntary medical male circumcision, microbicides, PrEP, and hormonal contraception use and HIV risk.
Intervention Update: Hormonal Contraception and HIV
Excerpted from AVAC Report: HIV Prevention on the Line, this update describes recent discussion and analysis in the search for answers as to whether hormonal contraceptives, including long-acting methods such as Depo-Provera (DPMA) and other injectable contraceptives and the implant, affect women’s risk of acquiring HIV.
Intervention Update: Voluntary Medical Male Circumcision
Excerpted from AVAC Report: HIV Prevention on the Line, this update cites the success of a previous VMMC target and suggests the current lack of a target moving forward will stifle continued progress.
Intervention Update: What’s Next for AIDS Vaccines and the P5 Partnership?
Excerpted from AVAC Report: HIV Prevention on the Line, this update details attempts to test vaccine strategy which showed promise in the RV144 trial.
Mind the Gap
This graphic, presented in the AVAC Report 2014/15: HIV Prevention on the Line, shows all the components of a comprehensive response to end the epidemic.
Change in Funding for Civil Society Organizations for Human Rights-Related Work
This graphic, presented in the AVAC Report 2014/15: HIV Prevention on the Line, shows the change in funding for civil society organizations for human-rights related work.
AVAC Report 2014/15: Prevention on the Line [Executive Summary]
This executive summary, excerpted from AVAC Report 2014/15, puts the current discussion about global targets for ending AIDS in context. What makes a good target? What targets have worked in the past—and why? What is the state of HIV prevention targets and plans today?
Essential Actions for HIV Prevention Research Rollout 2014/15
This updated version of AVAC’s 3D graphic shows priorities across the research-to-rollout spectrum. The graphic appears in AVAC Report 2014/15: Prevention on the Line.